Austock report:
There�s no negative news that we�re aware of on OGC, noting we recently factored in the guided NZ cash cost increase. However, we do see some upcoming positive catalysts:
1) 1Q�CY11:
* Reefton�s, Souvenir open pit Ore Reserve to potentially be pre-released January 2011.
* We expect +20% Ore Reserve growth at its NZ operations (primarily from Reefton Goldfield and optimisation for other NZ operations from higher gold price assumption (moving from US$800/oz to US$950/oz)). We would expect this to be released early February
* New CEO Mick Wilkes is on board (officially starts in February).
* We see CY10 Result could beat consensus, and expect release late February/early March.
2) Late 1Q/Early 2Q CY11:
* If Resource growth is material, and we expect this is more than likely, OGC will release a revised Reefton 43-101 Technical Report, including mine plan and cost profile
o This will be important as it will hopefully reinforce our view that a mine life extension from Reefton production is indeed possible.
o We expect this to add 3 years mine life out to CY17, and see this as a positive catalyst for de-risking Reefton Goldfield operations.
3) 2Q�CY11:
o Infill drilling of Round Hill open pit complete in preparation for studies (no Ore Reserve, but 1.44Moz Mineral Resource at present)
o Globe Deeps studies completed by end quarter in preparation for mining, noting that Globe is currently being mined.
4) Mid year Didipio site visit, we expect this to:
o help reinforce untapped value in Didipio exploration � potential for further porphyry discoveries from 12 targeted anomalies that are currently being mapped and surveyed in preparation for drilling during 2011.
o Provide an update on construction progress, we would expect progress details are released to market well ahead of the visit
We maintain our buy recommendation and $4.60/share PT, it�s now our #3 pick of gold and coppers under coverage. We see the price weakness as a very good buying opportunity.
- Forums
- ASX - By Stock
- OGC
- oversold?
oversold?, page-18
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OGC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online